ADVFN - Advanced Financial Network.
HOME» NASDAQ » G » GILD Stock Price » GILD Stock News

Gilead Sciences Share News

 Gilead Sciences (mm) Stock Price
GILD Stock Price
 Gilead Sciences (mm) Stock Chart
GILD Stock Chart
 Gilead Sciences (mm) Stock News
GILD Stock News
 Gilead Sciences (mm) Company Information
GILD Company Information
 Gilead Sciences (mm) Stock Trades
GILD Stock Trades

WSJ BLOG/Health: A.M. Vitals: GSK's Hostile Human Genome Bid; Regulators Like Preventive HIV Drug

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Christopher Weaver Here's what's making health news this morning: The ABCs of Beating Obesity (WSJ): A new Institute of Medicine report says schools should be a "national focal point" for the prevention of obesity, requiring, for instance, at least 60 minutes of physical activity a day. GSK Makes Hostile Human Genome Sciences Bid (WSJ): GlaxoSmithKline said it would take a $2.6 billion bid to buy Human Genome directly to shareholders after its smaller partner rejected the offer as too low. Regulator Seems to Back HIV Drug (WSJ): A memo released by Food and Drug Administration regulators Tuesday said Gilead Sciences' drug Truvada could spare people at risk for HIV "infection with a serious and life-threatening illness," a sign of support for what would be the first approval of a preventive HIV medicine. Psychiatry Manual Drafters Back Down on Diagnoses (New York Times): Amid protests from therapists, scientists and patients, the nation's top psychiatry association stripped its forthcoming index of diseases of two new disorders it concluded were not supported by evidence. Senate Inquiry Into Painkiller Makers' Ties (New York Times): Senators are probing ties between pharmaceutical companies that make pain pills and the patient groups, pain specialists and other groups that have advocated for broader use of the drugs. Retired Couples May Need $240,000 for Health Care (Associated Press): Fidelity Investments estimates that retired couples will need to reserve $240,000 for health care costs over the remainder of their lives, a number that could rise if the 2010 federal health law is repealed. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Gilead Sciences (GILD)
DateTimeHeadline
01/15/201500:11:45India Rejects Gilead Patent Bid
01/15/201500:05:25India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment...
01/08/201517:22:44AbbVie Predicts Sharp Increase in Earnings
01/04/201519:30:08Drug Prices to Get More Expensive -- Corporate Outlook
12/29/201420:26:24MARKET SNAPSHOT: S&P 500 Rises To Record, But Dow Snaps 7-day...
12/29/201420:23:11MARKET SNAPSHOT: S&P 500, Dow On Pace For Record Closes
12/29/201419:35:44MARKET SNAPSHOT: S&P 500 Hits Another Record As Stocks Edge Up
12/24/201412:21:07MARKET SNAPSHOT: U.S. Stocks Inch Higher As Santa Rally Stays...
12/24/201411:03:29MARKET SNAPSHOT: U.S. Stocks Inch Higher As Santa Stays Jolly
12/24/201411:02:54MARKET SNAPSHOT: U.S. Stocks Inch Higher; Oil Drops
12/22/201417:36:19U.S. Hot Stocks: Hot Stocks to Watch
12/11/201407:47:33GlaxoSmithKline Seeks Variation on Authorization for Ambrisentan
12/10/201416:11:30Philadelphia Agency Sues Gilead Over Price Of Hepatitis Drug--Update
12/10/201414:16:17Philadelphia Transit Agency Sues Gilead, Claiming Sovaldi Price-Gouging
10/29/201415:01:09Gilead: Buy the Dip -- Barron's
10/28/201406:48:25Biotech Bull Intact But Showing Signs of Age -- Barron's
10/27/201416:09:31Biotech Bull Intact But Showing Signs of Age
10/26/201405:18:37MARKET SNAPSHOT: Energy, Health Care Earnings To Dominate Week
10/24/201418:02:12Gilead Watchers Looking for Commentary on New Drug's Launch...
10/10/201414:15:14Press Release: FDA Approves First Combination Pill to Treat Hepatitis...

Gilead Sciences and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad